Skip to main content

Table 2 Distribution of the type of cancer in the study sample

From: A comprehensive evaluation of potentially significant drug-drug, drug-herb, and drug-food interactions among cancer patients receiving anticancer drugs

Cancer type

Frequency (%)

Breast cancer

124 (37.9%)

Colon cancer

40 (12.2%)

Multiple myeloma (MM)

25 (7.6%)

Non-hodgkin lymphoma (NHL)

25 (7.6%)

Hodgkin lymphoma (HL)

21 (6.4%)

Lung cancer

21(6.4%)

Ovarian cancer

17 (5.2%)

Pancreatic cancer

12 (3.7%)

Prostate cancer

7 (2.1%)

Gastric cancer

5 (1.5%)

Acute myeloid leukemia (AML)

5 (1.5%)

Acute lymphoblastic leukemia (ALL)

3 (0.9%)

Uterine cancer

2 (0.6%)

Gallbladder cancer

2 (0.6%)

Leiomyosarcoma

2 (0.6%)

Chronic lymphocytic leukemia (CLL)

2 (0.6%)

Bladder cancer

1 (0.3%)

Ewing cancer

1 (0.3%)

Adenocarcinoma of the leg

1 (0.3%)

Neuroendocrine

1 (0.3%)

Osteosarcoma

1 (0.3%)

Other types

9 (2.8%)